INCYTE CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
INCYTE CORPORATION (INCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-04-28
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-03-31 | 0.00% 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-02-10 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | 0.00% 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | 0.00% 10-Q · filed 2025-04-29 | |||
| 2024-12-31 | 0.00% 10-K · filed 2025-02-10 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2024-10-29 | |||
| 2024-06-30 | 0.00% 10-Q · filed 2024-07-30 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2024-04-30 | |||
| 2023-12-31 | 0.00% 10-K · filed 2024-02-13 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2023-10-31 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-01 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | 0.00% 10-K · filed 2023-02-07 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | 0.00% 10-K · filed 2022-02-08 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | 0.00% 10-K · filed 2021-02-09 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | 0.00% 10-K · filed 2020-02-13 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2019-10-29 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-07-30 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2019-04-30 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2018-10-30 | |||
| 2018-06-30 | 0.00% 10-Q · filed 2018-07-31 | |||
| 2018-03-31 | 0.00% 10-Q · filed 2018-05-01 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-10-31 | |||
| 2017-06-30 | 0.00% 10-Q · filed 2017-08-01 | |||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-04 | |||
| 2016-09-30 | 0.00% 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | 0.00% 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | 0.00% 10-Q · filed 2016-05-09 | |||
| 2015-09-30 | 0.00% 10-Q · filed 2015-11-03 | |||
| 2015-06-30 | 0.00% 10-Q · filed 2015-08-04 | |||
| 2015-03-31 | 0.00% 10-Q · filed 2015-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |